Recent FY results show the recent strength of Novo Nordisk in diabetes and obesity. So much so it is easy to forget the recency with which things weren’t so rosy. Beyond GLP-1s, we look at future ...
Researchers from Duke University have found that, under certain conditions, cells in the pancreas can produce GLP-1 – the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback